<!DOCTYPE html>
<html lang="en">
    <head>
        <meta charset="UTF-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">
        <meta http-equiv="X-UA-Compatible" content="ie=edge">
        <link rel="stylesheet" href="./css/style.css">
        <title>AMT PVT. LTD.</title>
    </head>
    <body>
        <header>
            <div class="container">
                <div class="brand"><span class="design">A</span>ROGYA M<span class="design">EDTECH</span></div>
                <nav>
                    <ul>
                        <li><a href="index.html" class="design">Home</a></li>
                        <li><a href="about.html">About Us</a></li>
                        <li><a href="services.html">Our Services</a></li>
                        <li><a href="contact.html">Contact Us</a></li>
                    </ul>
                </nav>
            </div>
        </header>
        
        <section id="showcase">
            <div class="cover">
                <div class="container">
                    <h1>Hi, We Are Arogya Medtech</h1>
                    <p>We Innovate And Revolutionalize</p>
                </div>
            </div>
        </section>

        <article class="welcome">
            <p>Welcome To</p>
            <h2>Arogya Medtech Pvt Ltd</h2>
        </article>

        <section>
            <div class="container">
                <div class="box">
                    <img src="./images/web dev.jpg" alt="">
                    <h2>CEREBROS</h2>
                    <p>CEREBROS™ - A novel, radical solution at the heart of which is a low-cost, portable, multimodal (electrocardiogram (ECG), electroencephalography (EEG) and functional near infrared spectroscopy (fNIRS), IoT (Internet of Things) device integrated with a tele-monitoring platform for continuous remote monitoring of cerebral hypoxia and seizures and early detection and management of HIE at point-of-care. The overarching objective of CEREBROS is to empower CHWs (ASHA, ANM) in rural hospitals to identify propensity for brain injury in HIE early and ensure early physiology-based treatment for "intact survival" under the remote tele-monitoring guidance of a neonatologist, such that neurological outcome is good.
</p>
                </div>
                <div class="box">
                    <img src="./images/index1.jpeg" alt="">
                    <h2>MINDEYE</h2>
                    <p>The technology, in conjunction with a battery of cognitive tasks, is nicknamed “MindEye.” It uses a low-cost infrared camera to detect subtle changes in pupil dilation and eye movement. These changes indicate cognitive impairment, which often begins years before other Alzheimer’s symptoms are visible. These changes, called saccadic eye movements, increase as the disease progresses.</p>
                </div>
                
            </div>
            <div class="clr"></div>
        </section>
    
        <section id="subscribe">
            <div class="container">
                <h3>Please Subsrcibe To Our News Letter</h3>
                <form action="">
                    <input type="email">
                    <input type="submit" value="Subscribe">
                </form>
            </div>
            <div class="clr"></div>
        </section>

        <footer>
            <div class="container">
                Copyright &copy; AMT : 2020
            </div>
        </footer>
    </body>
</html>
